Home > News By Company > RNCOS
Protein Therapeutics to Post Double Digit Growth by 2012
Global protein therapeutics market is forecasted to grow at a CAGR of over 11%, driven by increasing penetration of health insurance and improvements in drug delivery methods.
(EMAILWIRE.COM, September 16, 2009 ) New Delhi, India - Advancements in drug delivery methods and increasing prevalence of chronic disease have led the growth of protein therapeutics market in an effective manner. With rising demand for innovative protein therapeutics globally, investors have shown huge interest in the market. Our new research study “Global Protein Therapeutics Market Analysis” also anticipates that the protein therapeutics market worldwide will grow at a CAGR of over 11% to post a value of around US$ 118 Billion, ranking it one of the highest growing segments of pharmaceutical market.
According to our study, Monoclonal Antibody holds nearly half of the market share and this segment will continue to grow at a fast rate in future as well. Various factors, such as ageing population, increasing prevalence of chronic diseases, increasing penetration of health insurance, have strongly boosted the protein therapeutics market. Besides, Erythropoietin market represents another major segment of the market. At present, it holds around 14% of total therapeutics market and is expected to retain its share In future.
We have found that marketed protein-based therapeutics are characterized by high prices owing to the high costs involvement in research and developments of new therapeutics. In this regard, our research indicates that there are several ‘me-too products’ with virtually no difference in technology at various development phases worldwide. Once these products will be through the development process, the world will witness price-based competition in protein therapeutics market.
A Research Analysts at RNCOS said, “Several steps should be taken by governments to remove complexities in the approval system and to promote investment in dedicated research and development.”
“Global Protein Therapeutics Market Analysis” analyzes the key markets and segments of the Industry to give a brief about its future scenario. Besides, the report provides rationale analysis and forecast for various segments and sectors of the industry. It also discusses the factors fueling growth in the protein therapeutics market along with the challenges working as restraints for the industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM557.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
According to our study, Monoclonal Antibody holds nearly half of the market share and this segment will continue to grow at a fast rate in future as well. Various factors, such as ageing population, increasing prevalence of chronic diseases, increasing penetration of health insurance, have strongly boosted the protein therapeutics market. Besides, Erythropoietin market represents another major segment of the market. At present, it holds around 14% of total therapeutics market and is expected to retain its share In future.
We have found that marketed protein-based therapeutics are characterized by high prices owing to the high costs involvement in research and developments of new therapeutics. In this regard, our research indicates that there are several ‘me-too products’ with virtually no difference in technology at various development phases worldwide. Once these products will be through the development process, the world will witness price-based competition in protein therapeutics market.
A Research Analysts at RNCOS said, “Several steps should be taken by governments to remove complexities in the approval system and to promote investment in dedicated research and development.”
“Global Protein Therapeutics Market Analysis” analyzes the key markets and segments of the Industry to give a brief about its future scenario. Besides, the report provides rationale analysis and forecast for various segments and sectors of the industry. It also discusses the factors fueling growth in the protein therapeutics market along with the challenges working as restraints for the industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM557.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |